845 related articles for article (PubMed ID: 17508409)
1. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
[TBL] [Abstract][Full Text] [Related]
2. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.
Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG
Int J Mol Med; 2006 May; 17(5):937-44. PubMed ID: 16596284
[TBL] [Abstract][Full Text] [Related]
3. XPC mRNA level may predict relapse in never-smokers with non-small cell lung cancers.
Yeh KT; Wu YH; Lee MC; Wang L; Li CT; Chen CY; Lee H
Ann Surg Oncol; 2012 Mar; 19(3):734-42. PubMed ID: 21861227
[TBL] [Abstract][Full Text] [Related]
4. Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer.
Osoegawa A; Yoshino I; Tanaka S; Sugio K; Kameyama T; Yamaguchi M; Maehara Y
J Clin Oncol; 2004 Oct; 22(20):4165-73. PubMed ID: 15483027
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Jun activation domain-binding protein 1 in nonsmall cell lung cancer and its significance in p27 expression and clinical features.
Osoegawa A; Yoshino I; Kometani T; Yamaguchi M; Kameyama T; Yohena T; Maehara Y
Cancer; 2006 Jul; 107(1):154-61. PubMed ID: 16721818
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis.
Takanami I
Oncol Rep; 2004 Oct; 12(4):849-53. PubMed ID: 15375511
[TBL] [Abstract][Full Text] [Related]
8. Significance of skp2 expression in primary breast cancer.
Sonoda H; Inoue H; Ogawa K; Utsunomiya T; Masuda TA; Mori M
Clin Cancer Res; 2006 Feb; 12(4):1215-20. PubMed ID: 16489076
[TBL] [Abstract][Full Text] [Related]
9. CK19 mRNA expression measured by reverse-transcription polymerase chain reaction (RT-PCR) in the peripheral blood of patients with non-small cell lung cancer treated by chemo-radiation: an independent prognostic factor.
Chen TF; Jiang GL; Fu XL; Wang LJ; Qian H; Wu KL; Zhao S
Lung Cancer; 2007 Apr; 56(1):105-14. PubMed ID: 17166620
[TBL] [Abstract][Full Text] [Related]
10. The role of retinoid X receptor messenger RNA expression in curatively resected non-small cell lung cancer.
Brabender J; Danenberg KD; Metzger R; Schneider PM; Lord RV; Groshen S; Tsao-Wei DD; Park J; Salonga D; Hölscher AH; Danenberg PV
Clin Cancer Res; 2002 Feb; 8(2):438-43. PubMed ID: 11839661
[TBL] [Abstract][Full Text] [Related]
11. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of overexpression of Skp2 mRNA in non-small cell lung cancer.
Takanami I
Oncol Rep; 2005 Apr; 13(4):727-31. PubMed ID: 15756449
[TBL] [Abstract][Full Text] [Related]
13. XPC epigenetic silence coupled with p53 alteration has a significant impact on bladder cancer outcome.
Yang J; Xu Z; Li J; Zhang R; Zhang G; Ji H; Song B; Chen Z
J Urol; 2010 Jul; 184(1):336-43. PubMed ID: 20488473
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic significance of ERCC1 mRNA expression in patients with non-small cell lung cancer receiving platinum-based chemotherapy].
Qian XP; Liu BR; Shi MQ; Liu XZ; Hu WJ; Zou ZY; Wei J
Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):33-7. PubMed ID: 19538866
[TBL] [Abstract][Full Text] [Related]
15. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.
Tsai MF; Wang CC; Chang GC; Chen CY; Chen HY; Cheng CL; Yang YP; Wu CY; Shih FY; Liu CC; Lin HP; Jou YS; Lin SC; Lin CW; Chen WJ; Chan WK; Chen JJ; Yang PC
J Natl Cancer Inst; 2006 Jun; 98(12):825-38. PubMed ID: 16788156
[TBL] [Abstract][Full Text] [Related]
16. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
Metzger R; Vallbohmer D; Müller-Tidow C; Higashi H; Bollschweiler E; Warnecke-Eberz U; Brabender J; Baldus SE; Xi H; Berdel WE; Serve H; Hoelscher AH; Schneider PM
Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359
[TBL] [Abstract][Full Text] [Related]
17. Int6 expression can predict survival in early-stage non-small cell lung cancer patients.
Buttitta F; Martella C; Barassi F; Felicioni L; Salvatore S; Rosini S; D'Antuono T; Chella A; Mucilli F; Sacco R; Mezzetti A; Cuccurullo F; Callahan R; Marchetti A
Clin Cancer Res; 2005 May; 11(9):3198-204. PubMed ID: 15867213
[TBL] [Abstract][Full Text] [Related]
18. [Correlation analysis among expression of ERCC-1, metallothionein, p53 and platinum resistance and prognosis in advanced non-small cell lung cancer].
Huang PY; Liang XM; Lin SX; Luo RZ; Hou JH; Zhang L
Ai Zheng; 2004 Jul; 23(7):845-50. PubMed ID: 15248926
[TBL] [Abstract][Full Text] [Related]
19. Higher expression of RhoC is related to invasiveness in non-small cell lung carcinoma.
Shikada Y; Yoshino I; Okamoto T; Fukuyama S; Kameyama T; Maehara Y
Clin Cancer Res; 2003 Nov; 9(14):5282-6. PubMed ID: 14614010
[TBL] [Abstract][Full Text] [Related]
20. High MMP-1 mRNA expression is a risk factor for disease-free and overall survivals in patients with invasive breast carcinoma.
Cheng S; Tada M; Hida Y; Asano T; Kuramae T; Takemoto N; Hamada J; Miyamoto M; Hirano S; Kondo S; Moriuchi T
J Surg Res; 2008 May; 146(1):104-9. PubMed ID: 17663001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]